Get the Stockscreener App
41.78
2.98%
-1.205
Conmed Corp stock is traded at $41.78, with a volume of 168.35K.
It is down -2.98% in the last 24 hours and up +2.58% over the past month.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
See More
Previous Close:
$42.99
Open:
$42.26
24h Volume:
168.35K
Relative Volume:
0.29
Market Cap:
$1.28B
Revenue:
$1.32B
Net Income/Loss:
$110.20M
P/E Ratio:
11.80
EPS:
3.5417
Net Cash Flow:
$148.24M
1W Performance:
-9.07%
1M Performance:
+2.58%
6M Performance:
-24.12%
1Y Performance:
-27.59%
1-Day Range:
$41.24
$42.41
1-Week Range:
$41.24
$46.55
52-Week Range:
$35.37
$64.87
Conmed Corp Stock (CNMD) Company Profile
Name
Conmed Corp
Sector
Industry
Phone
727-214-2974
Address
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
41.67 | 1.33B | 1.32B | 110.20M | 148.24M | 3.5417 |
|
ABT
Abbott Laboratories
|
110.96 | 196.53B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
370.64 | 146.14B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
92.63 | 122.74B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
71.75 | 107.15B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
83.56 | 49.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-12-25 | Downgrade | Needham | Buy → Hold |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Feb-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-01-24 | Reiterated | Needham | Buy |
| May-22-23 | Initiated | CL King | Buy |
| Mar-27-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-21-23 | Initiated | Wells Fargo | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Oct-06-21 | Upgrade | Needham | Hold → Buy |
| Jul-15-21 | Initiated | UBS | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| Nov-26-19 | Downgrade | Needham | Buy → Hold |
| Nov-12-19 | Initiated | JP Morgan | Overweight |
| Oct-31-19 | Reiterated | Needham | Buy |
| Oct-04-19 | Reiterated | Needham | Buy |
| Aug-22-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Apr-18-19 | Initiated | Stifel | Buy |
| Apr-16-19 | Reiterated | Needham | Buy |
| Jan-23-19 | Reiterated | Needham | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Aug-07-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Apr-26-18 | Reiterated | Needham | Buy |
| Feb-01-18 | Reiterated | Needham | Buy |
| Jul-27-17 | Reiterated | Needham | Buy |
| Apr-27-17 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Apr-27-17 | Reiterated | Needham | Buy |
| Nov-18-16 | Reiterated | Needham | Buy |
| Jul-28-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-28-16 | Reiterated | Needham | Buy |
| Oct-22-15 | Reiterated | Northland Capital | Market Perform |
View All
Conmed Corp Stock (CNMD) Latest News
The Technical Signals Behind (CNMD) That Institutions Follow - Stock Traders Daily
Equity awards for CONMED (CNMD) VP Matthew Schabacker detailed in Form 4 - Stock Titan
CONMED Corp (NYSE: CNMD) treasurer awarded 5,896 RSUs - Stock Titan
CONMED (NYSE: CNMD) grants RSUs and stock options to EVP - Stock Titan
CONMED (NYSE: CNMD) EVP granted RSUs and stock options in 2026 award - Stock Titan
Equity awards granted to CONMED (CNMD) General Counsel Hollie Foust - Stock Titan
Equity grant: CONMED (CNMD) VP Corporate Controller receives 5,896 RSUs - Stock Titan
CONMED Earnings Reset Story After Strong Quarter And Higher Guidance - Yahoo Finance
CNMD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Conmed (CNMD) Up 22.9% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Assessing CONMED (CNMD) Valuation After Mixed Short And Long Term Share Price Performance - simplywall.st
Director Mark Kaye converts 152 RSUs at CONMED (NYSE: CNMD) into stock - Stock Titan
Momentum Shift: Does CONMED Corporation have declining or rising EPSMarket Activity Report & Precise Swing Trade Alerts - baoquankhu1.vn
3 Reasons CNMD is Risky and 1 Stock to Buy Instead - Finviz
Villanova Investment Management Co LLC Acquires New Shares in CONMED Corporation $CNMD - MarketBeat
Precision Trading with Conmed Corp.Ordinary Shares (CNMD) Risk Zones - Stock Traders Daily
CONMED (NYSE:CNMD) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Envestnet Asset Management Inc. Boosts Holdings in CONMED Corporation $CNMD - Defense World
Decoding Conmed Corp (CNMD): A Strategic SWOT Insight - GuruFocus
CONMED Corp SEC 10-K Report - TradingView
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now - Finviz
CONMED (NYSE:CNMD) Upgraded at Zacks Research - Defense World
A Look At CONMED (CNMD) Valuation After Earnings And Growth In Key Surgical Segments - simplywall.st
CONMED (NYSE:CNMD) Upgraded to Hold at Zacks Research - MarketBeat
5 Must-Read Analyst Questions From CONMED's Q4 Earnings Call - Finviz
5 Essential Analyst Inquiries from CONMED’s Fourth Quarter Earnings Discussion - Bitget
Earnings call transcript: CONMED Q4 2025 beats EPS forecasts, stock dips - Investing.com
Assessing CONMED (CNMD) Valuation After Q4 Results And Surgical Portfolio Shift - Yahoo Finance UK
Street Watch: Should I trade or invest in Taboolacom Ltd Equity Warrant2025 Pullback Review & Long-Term Growth Portfolio Plans - baoquankhu1.vn
CONMED Q4 Earnings Call Highlights - Defense World
Conmed Corporation stock hits 52-week low at 38.05 USD By Investing.com - Investing.com Nigeria
CONMED Stock Up Post Q4 Earnings and Revenue Beat, Gross Margin Up - Yahoo Finance
Conmed Corporation stock hits 52-week low at 38.05 USD - Investing.com
CNMD Q4 Deep Dive: Ortho Outperformance and Strategic Refocusing Shape 2026 Outlook - Finviz
CONMED Corporation (NYSE:CNMD) Q4 2025 Earnings Call Transcript - Insider Monkey
What Analysts Are Saying About Conmed Stock - Benzinga
Conmed Corp (CNMD) Q4 2025 Earnings Call Highlights: Strong Orthopedic Sales Drive Growth ... - Yahoo Finance
CONMED Corp shares slip after Q4 earnings beat, cautious guidance - AlphaStreet News -
Compared to Estimates, Conmed (CNMD) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
CONMED Q4 2025 presentation slides: Strong international growth drives earnings beat - Investing.com
CONMED (CNMD) Q4 2025 Earnings Call Transcript - AOL.com
CONMED Q4 Adjusted Earnings, Revenue Rise; 2026 Guidance Set - marketscreener.com
Earnings call transcript: CONMED beats Q4 2025 estimates, stock dips - Investing.com
Conmed: Q4 Earnings Snapshot - kare11.com
(CNMD) CONMED Expects 2026 Revenue Range $1.35B-$1.38B, vs. FactSet Est of $1.38B - marketscreener.com
(CNMD) CONMED Expects 2026 Adjusted Earnings Range $4.30-$4.45, vs. FactSet Est of $4.50 - marketscreener.com
CONMED (NYSE:CNMD) Beats Q4 CY2025 Sales Expectations, Stock Soars - Finviz
Conmed: Fourth Quarter Financial Highlights - Bitget
Conmed Corp. Profit Retreats In Q4 - Nasdaq
Earnings Flash (CNMD) CONMED Corporation Reports Q4 Revenue $373.2M, vs. FactSet Est of $366.9M - marketscreener.com
Is There Now An Opportunity In CONMED (CNMD) After Prolonged Share Price Weakness - Yahoo Finance
Conmed Corp Stock (CNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):